Dexcom G7 Continuous Glucose Monitoring System Launch and New Initiatives for College Athletes with Diabetes
In a significant stride toward enhancing diabetes management, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, has announced the upcoming launch of the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System in the United States. Set to debut on December 1, 2023, this new device is designed for people over the age of 18 living with diabetes, promising to revolutionize how individuals monitor and manage their glucose levels.
The Dexcom G7: A New Era in Glucose Monitoring’
The Dexcom G7 15 Day CGM system features a sleek, comfortable design that continuously monitors glucose levels for up to 15 days. This innovative system will initially be available through Durable Medical Equipment (DME) providers, ensuring convenience and accessibility for users who require diabetes management tools. Importantly, the Dexcom G7 15 Day has received coverage for Medicare beneficiaries and meets the requirements for therapeutic CGM systems, highlighting the company’s commitment to helping patients receive the necessary support for their condition.
Continuous glucose monitoring technology has changed the landscape of diabetes care by providing real-time glucose readings and trends, thus empowering users to take proactive measures in managing their health. The Dexcom G7 is expected to enhance this capability further, offering improved accuracy, a precision sensor technology, and a user-friendly interface that simplifies tracking for individuals with diabetes.
Dexcom U: Empowering College Athletes with Diabetes’
In conjunction with the launch of the Dexcom G7, DexCom is also excited to announce the fourth season of Dexcom U, its pioneering Name, Image, and Likeness (NIL) program aimed at college athletes living with diabetes. This initiative represents a significant investment in the health and representation of diabetic athletes in collegiate sports.
With an expanded roster for this season, Dexcom U will introduce 13 new athletes from esteemed institutions including the University of Oregon, San Diego State University, and Northwestern University, representing a diverse array of 12 sports. This program not only provides the athletes with opportunities to share their stories but also raises awareness about diabetes and fosters community among those sharing similar experiences.
Nationwide Search for Emerging Talent
A notable highlight of this season is the first-ever nationwide search for college athletes with diabetes to join the Dexcom U program. This open call serves as an invitation for athletes, coaches, family members, and friends to nominate inspiring college athletes to be part of this transformative initiative. Nominations will be accepted until May 23, offering a platform for passionate athletes to showcase both their sports skills and their journey with diabetes.
By launching this nationwide search, Dexcom aims to create an inclusive environment where athletes with diabetes can thrive, receive recognition, and uplift each other, thus breaking down the barriers often associated with managing health challenges in competitive sports.
Conclusion
As DexCom prepares to launch the Dexcom G7 15 Day Continuous Glucose Monitoring System, it stands at the forefront of advancing diabetes care and supporting the athletic aspirations of individuals living with diabetes. The combination of cutting-edge technology with programs that empower and recognize athlete contributions signifies a holistic approach to health and wellness that is evident in the company’s vision. With innovative solutions like the Dexcom G7 and the Dexcom U program, DexCom continues to make impactful strides in the lives of those managing diabetes, demonstrating that health and excellence in sport can coexist harmoniously.
Comments